Clark David J 4
4 · Trevi Therapeutics, Inc. · Filed Nov 14, 2022
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-11-14+300,000→ 300,000 totalExercise: $2.02Exp: 2032-11-13→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]This option was granted on November 14, 2022. The 300,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on November 14, 2023 and as to the remaining 75% of the shares in equal monthly installments thereafter, through November 14, 2026.